Thursday, July 5, 2018

Hot Dividend Stocks To Invest In 2019

tags:PTIE,ESLT,AUPH,

LSB Industries (NYSE: LXU) and Minerals Technologies (NYSE:MTX) are both multi-sector conglomerates companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Dividends

Get LSB Industries alerts:

Minerals Technologies pays an annual dividend of $0.20 per share and has a dividend yield of 0.3%. LSB Industries does not pay a dividend. Minerals Technologies pays out 4.4% of its earnings in the form of a dividend.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for LSB Industries and Minerals Technologies, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LSB Industries 0 0 0 0 N/A Minerals Technologies 0 1 0 0 2.00

Earnings & Valuation

Hot Dividend Stocks To Invest In 2019: Pain Therapeutics(PTIE)

Advisors' Opinion:
  • [By Chris Lange]

    Pain Therapeutics Inc. (NASDAQ: PTIE) shares were destroyed on Wednesday after a vote from the U.S. Food and Drug Administration (FDA) was announced. As we have said before, the FDA has the potential to make or break biopharmaceutical companies. In this case, Pain Therapeutics has been broken.

  • [By Lisa Levin] Gainers Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. 21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82. Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87. HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50 Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62. Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11. Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33. Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55. Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday. Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results. Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13. Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19. Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance. ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating. Biolinerx Ltd/S ADR (NASDAQ: BLRX)
  • [By Peter Graham]

    Small cap pain stock Pain Therapeutics (NASDAQ: PTIE) has elevated short interest of 35.77% according to Highshortinterest.com. Pain Therapeutics�develops proprietary drugs that offer significant improvements to patients and physicians.�The Company��s�expertise consists of developing new drugs and guiding these through various regulatory and development pathways in preparation for their eventual commercialization with a focus�on drug development efforts around disorders of the nervous system.�The FDA has not yet established the safety or efficacy of�any drug candidates. Pain Therapeutics���pipeline of drug assets includes:

  • [By Brian Orelli]

    DURECT Corp. (NASDAQ:DRRX) is down 9.2% at 12:45 p.m. EDT after the U.S. Food and Drug Administration's advisory committee voted�14 to 3 recommending the agency not approve Remoxy ER, an abuse-deterrent extended-release pain medication being developed by its partner Pain Therapeutics�(NASDAQ: PTIE).

Hot Dividend Stocks To Invest In 2019: Elbit Systems Ltd.(ESLT)

Advisors' Opinion:
  • [By Stephan Byrd]

    BidaskClub upgraded shares of Elbit Systems (NASDAQ:ESLT) from a sell rating to a hold rating in a report issued on Wednesday.

    Several other equities research analysts have also weighed in on the company. ValuEngine upgraded Elbit Systems from a hold rating to a buy rating in a report on Thursday, March 1st. TheStreet lowered Elbit Systems from a b rating to a c+ rating in a report on Tuesday, May 29th. Finally, Chardan Capital restated a neutral rating on shares of Elbit Systems in a report on Friday, June 1st. Five investment analysts have rated the stock with a hold rating, Elbit Systems presently has an average rating of Hold and an average price target of $176.00.

  • [By Logan Wallace]

    Shares of Elbit Systems Ltd (NASDAQ:ESLT) have been given an average rating of “Hold” by the five research firms that are covering the company, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation.

  • [By Lisa Levin] Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) rose 7.3 percent to $6.90 in pre-market trading after the company reported the FDA approval of TX-004HR: IMVEXXY (estradiol vaginal inserts) for moderate to severe dyspareunia due to menopause. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 6.1 percent to $10.50 in pre-market trading after falling 1.20 percent on Tuesday Movado Group, Inc. (NYSE: MOV) shares rose 5.7 percent to $44.60 in pre-market trading after the company reported better-than-expected Q1 results and raised its guidance. salesforce.com, inc. (NYSE: CRM) rose 5.4 percent to $133.67 in pre-market trading after the company reported better-than-expected earnings for its first quarter and raised its forecast for the full year. Sirius XM Holdings Inc. (NASDAQ: SIRI) rose 5.3 percent to $7.35 in pre-market trading. PagSeguro Digital Ltd. (NYSE: PAGS) rose 5.3 percent to $33.50 in pre-market trading after reporting Q1 results. SpartanNash Co (NASDAQ: SPTN) rose 4.9 percent to $19.80 in pre-market trading after the company reported upbeat earnings for its first quarter on Tuesday. Groupon, Inc. (NASDAQ: GRPN) rose 4.9 percent to $4.95 in pre-market trading. Dalian Wanda will set up a joint venture with Tencent and Groupon's former local unit, Reuters reported. Okta, Inc. (NASDAQ: OKTA) rose 4.4 percent to $56 in pre-market trading after gaining 3.43 percent on Tuesday Elbit Systems Ltd. (NASDAQ: ESLT) rose 4.3 percent to $120.92 in pre-market trading after gaining 2.05 percent on Tuesday. STMicroelectronics N.V. (NYSE: STM) shares rose 3.7 percent to $23.78 in pre-market trading after falling 4.70 percent on Tuesday. EVINE Live Inc (NASDAQ: EVLV) shares rose 2.7 percent to $1.14 in pre-market trading after reporting Q1 results.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Hot Dividend Stocks To Invest In 2019: Aurinia Pharmaceuticals Inc(AUPH)

Advisors' Opinion:
  • [By Logan Wallace]

    Isotechnika Pharma Inc. (NASDAQ:AUPH) (TSE:AUP) shares rose 6.7% during trading on Friday . The stock traded as high as $5.68 and last traded at $5.59. Approximately 54,590 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 429,596 shares. The stock had previously closed at $5.24.

  • [By Keith Speights]

    That statement comes to mind when I think about Aurinia Pharmaceuticals (NASDAQ:AUPH). The potential for the clinical-stage biotech appears to be so great that getting greedy with the stock is tempting.�

  • [By Cory Renauer]

    Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH),�a clinical-stage biotech, are on the rise following the company's first-quarter earnings report. Plans to expand voclosporin, the company's lupus candidate, to a much larger indication inspired investors to push the shares 10.2% higher as of 1:03 p.m. Monday.

No comments:

Post a Comment